SeH. The selenium-containing product of this reaction was identified by mass spectrometry. Nascent methylselenol was found to efficiently reduce both H 2 O 2 and glutathione disulfide. The implications of these findings for the antitumor activity of selenium are discussed. Methylseleninate was a poor substrate not only for human glutathione reductase but also for the non-selenium thioredoxin reductases enzymes from Drosophila melanogaster and Plasmodium falciparum. This suggests that the catalytic selenocysteine residue of mammalian thioredoxin reductase is essential for methylseleninate reduction.
Biochemical and clinical evidence indicates that monomethylated selenium compounds are crucial for the tumor preventive effects of the trace element selenium and that methylselenol (CH 3 SeH) is a key metabolite. As suggested by Ganther (Ganther, H. E. (1999) Carcinogenesis 20, 1657-1666), methylselenol and its precursor methylseleninate might exert their effects by inhibition of the selenoenzyme thioredoxin reductase via the irreversible formation of a diselenide bridge. Here we report that methylseleninate does not act as an inhibitor of mammalian thioredoxin reductase but is in fact an excellent substrate (K m of 18 M, k cat of 23 s ؊1 ), which is reduced by the enzyme according to the equation 2 NADPH ؉ 2 H ؉ ؉ CH 3 SeO 2 H 3 2 NADP ؉ ؉ 2 H 2 O ؉ CH 3 SeH. The selenium-containing product of this reaction was identified by mass spectrometry. Nascent methylselenol was found to efficiently reduce both H 2 O 2 and glutathione disulfide. The implications of these findings for the antitumor activity of selenium are discussed. Methylseleninate was a poor substrate not only for human glutathione reductase but also for the non-selenium thioredoxin reductases enzymes from Drosophila melanogaster and Plasmodium falciparum. This suggests that the catalytic selenocysteine residue of mammalian thioredoxin reductase is essential for methylseleninate reduction.
The trace element selenium is known to possess tumor preventive and other health beneficial activities (1) (2) (3) (4) (5) . Monomethylated selenium derivatives are crucially involved in these chemopreventive effects, and methylselenol (CH 3 SeH, CAS No. 6486-05-1) is considered a key metabolite (Ref. 6 and Fig. 1) . The mechanisms by which selenium exerts these effects is still unresolved. Recently, Howard Ganther (8) suggested that methylselenol might act by forming a diselenide bridge with the essential selenocysteine residue in mammalian thioredoxin reductase (7) , which would lead to an inhibition of the enzyme (8) . As judged from model peptides, such diselenide bridges possess a very low midpoint potential (R-SeH ϩ RЈ-SeH ª R-Se-Se-RЈ; ⌬E 0Ј Ϫ381 mV; see Ref. 9 ) and should therefore be very stable under physiological conditions. This model is attractive since the homodimeric flavoenzyme thioredoxin reductase (TrxR, 1 EC 1.6.4.5, thioredoxin-S 2 ϩ NADPH ϩ H ϩ ª thioredoxin-(SH) 2 ϩ NADP ϩ ) and its genuine substrate thioredoxin (Trx) are involved in a multitude of cellular metabolic and regulatory pathways, many thereof known to be of importance or (like the reduction of ribonucleotides by ribonucleotide reductase) even essential for the propagation of neoplastic and other diseases. However, due to the involvement of the thioredoxin system in the defense against oxidative stress, the inhibition of TrxR may not be solely beneficial (10 -13) .
To test the above hypothesis, mice were fed with methylseleninic acid (CH 3 SeO 2 H), a precursor of methylselenol (14) . The rodents showed no alteration in TrxR levels and activities. In an in vitro approach, the compound appeared to be a weak competitive inhibitor of TrxR. The concentrations required for inhibition were too high to be of physiological importance. Due to the lack of highly purified enzyme, experiments using quasiphysiologic concentrations of enzyme, NADPH, and methylseleninate were not conducted (14) . As reported here, we were also unable to find any inhibition in typical incubation experiments using pure enzyme. However, we noticed an unpleasant smell in the sample containing TrxR, methylseleninate, and NADPH that was absent in NADPH-free samples. This indicated the presence of volatile methylselenol as a product of a TrxR-catalyzed reaction ( Ref. 20) , and recombinant human thioredoxin (hTrx) in form of the stable His-tagged mutant C73S was provided by Heiko Merkle, Heidelberg, Germany. Bovine insulin, catalase, and superoxide dismutase were purchased from Sigma.
Reagents-Methylseleninic acid (CH 3 SeO 2 H, purity Ն 99.9%) was obtained from PharmaSe Inc. (Lubbock, TX). 127 mg (1 mmol) of methylseleninic acid was weighed out and dissolved in 500 l of 2 M KOH. 500 l of 100 mM potassium phosphate, 2 mM EDTA, pH 7.4 (T buffer) was added to yield a final concentration of 1 M potassium methylseleninate (CH 3 SeO 2 K). This stock solution was stored frozen. Dilute solutions (in T buffer) were prepared daily and kept on ice.
NADPH was from Biomol (Hamburg, Germany), glutathione and * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed: Im Neuenheimer Feld 328, Biochemiezentrum Heidelberg, 5. OG, D-69120 Heidelberg, Germany. Tel.: 49-6221-54-4175; Fax.: 49-6221-54-5586; E-mail: Stephan.Gromer@gmx.de. glutathione disulfide were from Roche Molecular Biochemicals, and dimethyldiselenide (CH 3 SeSeCH 3 ) was from Acros Organics N.V. (Geel, Belgium). Auranofin was bought from ICN (Aurora, OH). All other reagents were of the highest available purity and were purchased either from Sigma, Roth, Serva, or Merck.
Enzyme Concentrations-Enzyme concentrations were determined by the absorbance at 463 nm (PfTrxR, DmTrxR) using an ⑀ 463 nm of 11.3 mM Ϫ1 cm Ϫ1 . For human and murine TrxR, we made use of the experimental relation between activity in the (bovine serum albumin-free) DTNB reduction assay and subunit concentration: 1 enzyme unit/ml ϵ 520 nM subunit (21) .
Assay Procedures-For all assays, T buffer (100 mM potassium phosphate, 2 mM EDTA, pH 7.4) was used. Where applicable, solutions were made anaerobic using alternating cycles of vacuum and flushing with nitrogen (22) . For standard TrxR activity determination at 25°C, we used the DTNB reduction assay (23, 24) , the thioredoxin reduction assay (24) , and the GHOST (Glutathione as substrate of thioredoxin) assay (24) .
DTNB Reduction Assay (23, 24) -The enzyme was added to an assay mixture consisting of T buffer and 3 mM DTNB (100 mM stock solution in Me 2 SO); after initiating the reaction with the addition of NADPH (200 M final concentration), the increase in absorbance at 412 nm was monitored. One enzyme unit is defined as the NADPH-dependent production of 2 mol of 2-nitro-5-thiobenzoate (⑀ 412 nm 13 Peroxidase Assays in the Presence of CH 3 SeO 2 Ϫ -Hydroperoxides were studied as substrates using H 2 O 2 and t-butyl-hydroperoxide. The peroxidase activity of hTrxR was determined by observing the decrease in absorbance at 340 nm (⑀ 340 nm 6.22 mM Ϫ1 cm Ϫ1 ) in an assay containing hTrxR, 100 M NADPH in the absence and presence of 40 M hydroperoxide (final concentrations). After 5 min, methylseleninate was added ad 10 M. In a modification of this experiment, 100 nM of the TrxR inhibitor auranofin was added thereafter.
Protective effects against auranofin-mediated inhibition of TrxR by the nascent methylselenolate were investigated in an assay containing 3 nM hTrxR subunit, 10 M methylseleninate, and 100 M NADPH. When reduction of the methylseleninate was complete, the hTrxR inhibitor auranofin was added ad 500 nM (ratio [CH 3 Se Ϫ ]:
[auranofin] ϭ (20:1). After 1 min, methylseleninate was added to determine remaining enzymatic activity.
Preincubation Study-1 M hTrxR-subunit was incubated with and without 200 M NADPH either in the presence or in the absence of 1 M methylseleninate. After 15 min, 1-l samples were withdrawn, and the activity was determined in the DTNB reduction assay (assay volume, 1 ml). The remaining solutions were dialyzed exhaustively against T buffer and assayed for oxidase activity.
Methylselenol Production and Identification-To verify the formation of the presumed product (methylselenol), we made use of the fact that selenols precipitate as silver-colored selenolates when passing through an aqueous AgNO 3 solution. An apparatus essentially as described in Ref. 25 was used. The experiment was carried out in a hood since volatile selenium compounds are toxic. 100 mg of NADPH was dissolved in 500 l of T buffer in a gas-tight vial with a rubber septum and made anaerobic by flushing with oxygen-free nitrogen. 1.5 nmol of hTrxR subunit and 32 mol of methylseleninate (from neutralized stock solution) were dissolved in a total of 1700 l of degassed T buffer. The solution was made anaerobic by flushing with oxygen-free nitrogen (70 ml min Ϫ1 ) under continuous stirring for 20 min. Then the anaerobic NADPH was added rapidly under uninterrupted nitrogen flow. A few minutes later, a yellow brownish precipitate was formed in the 0.1 M AgNO 3 trapping solution. After 30 min, 1 ml of 50% H 3 PO 4 was added to the enzyme solution to volatilize remaining CH 3 Se anions. The pK a of selenols is ϳ5.7. Thus at pH 7.4 (T buffer), the majority of the produced methylselenol is present as the deprotonated methylselenolate (for comparison, pK a (of thiols Ն 8.5), see Ref. 9) . Nitrogen flushing was continued for another 15 min. The trapping vial containing the precipitate was centrifuged. If the precipitate was adhering to the vial surface, the closed vial was put into an ultrasonic bath for a few minutes. To remove remaining AgNO 3 , the dark yellow precipitate was resuspended twice in distilled water and centrifuged. A sample of the precipitate was then spread on a chromium-coated sample target and subjected to laser desorption/ionization (LDI) mass spectrometry. A Bruker-Biflex timeof-flight (TOF) instrument in positive-ion reflector mode with pulsed ion extraction was used for this purpose. As a positive control, synthetic methylselenol was produced (26) : in an anaerobic solution, 30 mol of methylseleninic acid was reduced using zinc as the reductant. The reaction was initiated by adding an equal volume of anaerobic 50% (w/v) H 3 PO 4 . The formed methylselenol was trapped as described above.
Glutathione Disulfide as a Substrate of Methylselenol-The reactivity of the nascent methylselenol with glutathione disulfide was studied in a modified GHOST assay using varying concentrations of GSSG as a final substrate. GSSG was added to an assay also containing hTrxR and NADPH (200 M) after the reduction of methylseleninate was complete. The formed GSH (in an assay containing 1 M methylselenolate and 50 M GSSG) was confirmed using DTNB ad 1 mM, which yields 1 TNB per thiol-/selenol group. Prior to the addition of the DTNB, 2 M of auranofin was added to eliminate the reduction of DTNB by TrxR (15, 27) . The change in absorbance at 412 nm (⑀ 412 nm TNB 13.6 mM Ϫ1 cm Ϫ1 ) was determined and compared with a GSSG-free control sample treated alike. Relevant glutathione reductase contaminations were ruled out.
FIG. 1.
Simplified mammalian selenium metabolism. Selenium is normally taken up from the gut mainly as selenomethionine, selenocyst(e)ine, selenate, and selenite. The total body selenium content is ϳ0.15 mg kg Ϫ1 . Most of the compounds absorbed are converted to selenide, which is then, depending on the cellular needs, either converted to selenophosphate (which in turn reacts with a tRNA loaded with serine to tRNA Sec ) or methylated. Note that there is no relevant pathway for the synthesis of selenomethionine in the mammalian metabolism. Probably in order to prevent too high levels of Sec, which would lead to a replacement of Cys by Sec, selenocysteine can be converted to Se-methylselenocysteine, which is cleaved to methylselenol. Selenide is reported to exert DNA-toxic effects, whereas methylselenol is reported to be crucially involved in the beneficial effects of selenium. Selenium is excreted mainly via the urinary tract as the trimethylselenonium ion. At higher concentrations, selenium is also exhaled as dimethylselenide, responsible for the garlic-like odor in selenium intoxication. Adapted from Refs. 43 and 44.
RESULTS

TrxR Catalyzes the Reduction of Methylseleninate to
Methylselenol-In the initial study in which we incubated hTrxR, NADPH, and methylseleninate, we could not detect a difference in activity between the samples with and without methylseleninate either in the presence or in the absence of NADPH. However, the sample containing NADPH and methylseleninate had a striking putrid odor. A direct reaction of the selenium compound with NADPH was ruled out in an assay without enzyme. This indicated that methylseleninate was a substrate of hTrxR. Consecutive experiments using various concentrations of methylseleninate as the electron acceptor validated this view. NADPH was stoichiometrically consumed by the methylseleninate as determined by the decrease in absorbance at 340 nm. A consumption of 2 mol of NADPH per mol of methylseleninate was established. This is consistent with the proposed overall reaction shown in Eq. 1.
Auranofin, a potent inhibitor of mammalian TrxR, inhibited the reaction completely. This effect of auranofin on TrxR activity could not be prevented by a 20-fold excess of methylselenol formed prior to the addition of inhibitor. The formation of methylselenol (CH 3 SeH), the presumed product of the TrxR-catalyzed reaction, was confirmed using LDI-TOF mass spectrometry (Fig. 2) .
As mammalian TrxR reacts with only one NADPH per catalytic cycle (15, 22, 28) , it must be concluded that the above overall reaction in Eq. 1 is the net result of the enzymatic reactions shown in Eqs. 2 and 3.
Alternatively, the initially formed CH (Table I) . Whereas the selenium-containing mouse enzyme behaves virtually like the human enzyme, we found different catalytic efficiencies with the compound in the case of the non-selenium enzymes from P. falciparum and D. melanogaster. The C-terminal sequence (Cys-XXXX-Cys) of the plasmodial enzyme differs from the typical Cys-Sec or Cys-Cys motif, and differences in kinetics and affinities are therefore not too surprising. Furthermore, selenium has not yet been established to be essential for this organism. The presence or absence of a selenium-containing glutathione peroxidase is still not established. The TrxR enzyme of the fruit fly is a Cys-Cys homologue of the human Cys-Sec sequence. Nevertheless, its affinity to methylseleninate is low. When first discovered, it was a surprise that the enzyme showed activities for the reduction of thioredoxin and DTNB in the same order of magnitude as the mammalian enzyme, whereas the Cys mutant of the rat TrxR exhibits about 1% of the activity of the wild-type enzyme only (31) .
This finding is interesting since it suggests that the selenolate of the enzyme reacts with the selenium of methylseleninate (Eq. 2) and methylselenenate (Eq. 3), respectively. We must then ask why this does not lead to the formation of an inactivating diselenide bridge. From an evolutionary point of view, it may be argued that the selenocysteine residue in hTrxR would not have been conserved if it were capable of forming a kinetically and thermodynamically stable diselenide. We suspect that the local environment has a so far underestimated influence on the redox potential of diselenide and selenylsulfide bridges. Studies done on mutant Trx support this point of view (32) (Fig. 3) . The addition of further enzyme did not enhance this NADPH oxidation, indicating that the enzyme was not limiting. The addition of further methylseleninate did re- ) after extensive dialysis if compared with enzyme treated alike but in the absence of methylseleninate. We therefore concluded that the product methylselenol reacted with oxygen (e.g. CH 3 Se Ϫ ϩ O 2 3 CH 3 SeO 2 Ϫ ), giving rise to an oxidation product, which again is a substrate of TrxR. In an anaerobic assay, we confirmed that NADPH consumption was equal to methylseleninate-free control after the calculated consumption of NADPH required for the full reduction of methylseleninate had taken place (Fig. 3) .
The TrxR/Methylselenol System Has Peroxidase Activity-As the above experiment indicates that methylselenol is very labile against oxidants, we examined the effect of peroxides on the system. The intrinsic peroxidase activity of TrxR (ϳ0.4 s
Ϫ1
) is very low. In the presence of 10 M methylseleninate/methylselenolate, however, this base-line activity was increased 22-fold for H 2 O 2 (40 M) and almost 7-fold for t-butyl-hydroperoxide (40 M). The NADPH consumption was again stoichiometric for the amount of peroxide and methylseleninate used. Taking into account the oxidation of methylselenolate according to Eq. 5,
1 mol of hTrxR subunit indirectly reduces ϳ9 mol of H 2 O 2 /s under these conditions, shown in Eq. 6,
The (re)formed methylseleninate (or methylselenenate) is then recycled according to Eq. 1, resulting in an overall reaction identical to the reaction sequence performed by glutathione peroxidase and glutathione reductase or the artificial and effective antioxidant ebselen (30) .
The TrxR/Methylselenolate System Efficiently Reduces Glutathione Disulfide-It is noteworthy that methylseleninate, in the absence of reduced glutathione, is virtually not a substrate for glutathione reductase (less than 0.05% of GSSG reduction activity). We found that in the presence of GSSG, which in turn is not a substrate of hTrxR (35) , there was a continuous consumption of NADPH after the complete reduction of methylseleninate (Fig. 4) , which was stoichiometric to the amount of GSSG added. For the reduction of GSSG by CH 3 SeH under steady-state conditions, a rate-constant k 2 of ϳ400 M Ϫ1 s Ϫ1 was calculated (19) . In a separate experiment, we determined the concentration of thiols formed with DTNB relative to a control without GSSG addition. As determined by the formation of 2-nitro-5-thio-benzoate (TNB), 95% of the 50 M GSSG added had been reduced to GSH by 1 M methylselenolate whose concentration was kept constant by hTrxR. (In this experiment, it is of importance to completely inhibit hTrxR with auranofin prior to the addition of 5,5Ј-dithiobis(2-nitrobenzoate) (DTNB) since it is a substrate of the enzyme under these conditions.) These results are in accordance with the proposed overall reaction shown in Eq. 7,
Eq. 7 is the sum of the theoretical Eqs. 8 and 9, shown below.
Eq. 8 is a spontaneous reaction. The reduction of GS-SeCH 3 (Eq. 9) is supposedly enzyme-dependent as the addition of further TrxR increased the rate of NADPH consumption indicative for an enzyme being involved. To rule out that the intermediate GS-SeCH 3 could also be cleaved by another molecule of methylselenol as depicted in Eq. 10, we tested dimethyldiselenide (CH 3 Se-Se-CH 3 ) as a substrate of TrxR. In a cuvette (total assay volume, 1 ml) containing 100 M NADPH in T buffer, 9 nM human thioredoxin reductase subunit was added. In the first experiment (dash-dotted line), GSSG (50 l) was then added ad 1 mM. The lack of a significant NADPH consumption indicates the absence of a relevant amount of glutathione reductase in the thioredoxin reductase enzyme sample. After a few minutes, methylseleninate was added ad 2.5 M. This initiated the reduction of GSSG by the formed methylselenol. If methylseleninate was added prior to the GSSG (solid line), only a stoichiometric NADPH consumption for the reduction to methylselenol can be detected. The addition of GSSG ad 1 mM led again to a stoichiometric consumption of NADPH. The assays were carried out under aerobic conditions. If this reaction (Eq. 10) was of quantitative importance, the reduction of dimethyldiselenide by TrxR would be a prerequisite for a continuous GSSG reduction as the reaction would otherwise come to an early halt. Dimethyldiselenide did not serve as a substrate of hTrxR under our assay conditions, most likely due to the unfavorable ⌬E 0Ј of the diselenide bridge. Reduced glutathione reduces methylseleninate quickly (29) . The attempt to quantify the effects of different c(GSH)/c(GSSG) ratios failed since the reaction was too rapid to give reproducible results with higher GSH concentrations.
Inhibitory Effects of Methylseleninate May Be Assay Artifacts-The weak competitive inhibition found for methylseleninic acid in an earlier study (14) may be partly due to the used assay system. The K m values of human TrxR for thioredoxin and methylseleninate are very similar (Table 1 and Refs. 22 and 35) . Thus in the presence of thioredoxin and methylseleninate, the concentrations of either substrate determines the rate of reduction of the individual compounds. Methylselenol, however, reduces insulin less efficiently (ϳ12% at equal concentration, data not shown). Because the formation of free thiols via the recycling of Trx is the principle of the insulin reduction assay, increasing methylseleninate concentrations leads to an apparent inhibition if the incubation time is short. For the DTNB reduction assay, similar considerations apply: the DTNB concentration is at least 5-20 times higher than is the K m of 18 M for methylseleninate (22, 35) . Because the formation of TNB is recorded in the DTNB reduction assay, it is obvious that the NADPH consumption due to the reduction of methylseleninate is not monitored directly. The nascent methylselenolate, however, does react with DTNB but forms only one TNB-thiolate anion in contrast to the two produced by the enzymatic DTNB reduction. From the theoretical point of view, methylseleninate might be viewed a competitive inhibitor if DTNB is regarded as the substrate. This does not reflect a physiological situation, however.
DISCUSSION
The biochemical mechanisms by which methylselenol exerts its beneficial effects are largely unknown. Recently, Howard Ganther (8) proposed the diselenide hypothesis. According to this hypothesis, the intermediates of the selenium metabolism, methylselenol or methylselenenate ( Fig. 1 and Refs. 3 and 4), would form stable diselenide bridges with essential Sec residues of selenoenzymes. This would result in irreversible inhibition of these enzymes since the reduction potentials of disulfides, selenylsulfides, and diselenides, as judged from model peptides, differ greatly. (Cys-Cys, Ϫ205 mV; Sec-Cys, Ϫ326 to Ϫ332 mV; Sec-Sec, Ϫ381 mV; Refs. 9 and 36. It must, however, be pointed out that the local environment in a protein and/or membrane may strongly influence these values (32) .)
Human thioredoxin reductase, which contains Sec496 as a catalytic residue (15, 22, 28, 31, 37) , was recommended a test case, e.g. enzyme-SeH ϩ CH 3 SeOH 3 enzyme-Se-Se-CH 3 ϩ H 2 O. Consecutive in vivo experiments were unable to support this hypothesis (14) .
To rule out that this lack of an in vivo effect was due to a metabolic pathway that prevents the selenium compound from reacting with TrxR in the living organism, we performed in vitro studies using the purified human enzyme since an inhibition under these conditions might then allow the design of a novel and highly selective class of TrxR inhibitors. Unexpectedly, methylseleninate, the stable precursor of methylselenol, not only did not act as an inhibitor of the enzyme but in fact turned out to be an excellent substrate of human TrxR. The stoichiometry of the reaction with NADPH was found to be 2 mol of NADPH/mol of methylseleninate. This is consistent with the proposed overall reaction Eq. 1 (2 NADPH ϩ 2 H ϩ ϩ
The data obtained by LDI-TOF mass spectrometry of a silver precipitate provided clear evidence for methylselenolate as a product.
As mammalian TrxR reacts with only one NADPH per catalytic cycle (15, 22, 28) , it must be concluded that the above overall reaction is the net result of two reactions as depicted in Eqs. 2 and 3. In the course of the reactions, methylseleninate, methylselenenate, and methylselenolate are present at one time or another. Since we do not observe any inhibition of TrxR activity in the concentration range used, we conclude that simple monomethylated selenium derivatives do not exert their chemopreventive effect by inhibition of TrxR. The lack of effect in vivo is not due to an unexpected pathway preventing the reaction. It may be argued that the TrxR-catalyzed reduction of methylseleninate and consecutive reactions are of negligible importance in the cell since GSH is present in abundance. However, similar theoretical assumptions had formerly been made for the reduction of selenite in which it has recently been shown that the depletion of reduced glutathione hardly alters the rate of selenite reduction in vivo, whereas NADPH is required (38) . The concentration of 25 M 1,3-bis-(2-chlorethyl)-1-nitrosourea used in Ref. 38 was too low for a complete inhibition of TrxR (16, 22) . This substantiates the finding that selenite can be efficiently reduced by TrxR to yield selenide (39) .
Many studies indicate that selenium is most preventive in the early stages of a neoplastic transformation (1, 40) . Reactive oxygen species (ROS) are considered important contributors on the cellular way to tumor formation. Therefore the finding that methylselenolate is readily oxidized by H 2 O 2 and to a lesser extent by other hydroperoxides such as t-butyl-hydroperoxide and thereby detoxifies these reactive compounds is of interest. The product of these reactions is methylseleninate (or methylselenenate), which will then be recycled to methylselenol (Eq. 1), resulting in the overall reaction identical to the reaction sequence performed by glutathione peroxidase and reductase.
Similar findings have been reported by Björnstedt et al. (41) with catalytically generated selenols from selenocystine. However, the intracellular concentration of selenocysteine is considered to be low (30) , and the cellular levels of selenocysteine and selenomethionine are regulated. Indeed, if the concentrations are increasing above a certain level, the selenoamino acids are metabolized to methylselenol (Fig. 1) . The physicochemical properties of methylselenol are advantageous for many functions: it is a small molecule that in its protonated form (ϳ8% at pH 6.9 using a pK a of 5.7) can easily pass through and act within membranes without any transport system. This is not the case for many other antioxidants such as ascorbate and glutathione. In the absence of oxidative stress and in the presence of a functional glutathione system, the involvement of TrxR in the maintenance of the methylselenol level may be negligible. However, under certain (patho)physiological conditions and in some compartments, TrxR-catalyzed methylselenol formation is likely to be of importance.
As the pK a increases in hydrophobic environments, methylselenol will further concentrate in membranes. There it may, apart from the cleavage of hydroperoxides, be capable of reducing other reactive oxygen species (CH 3 SeH ϩ "ROS" 3 CH 3 SeO 2 Ϫ ϩ H ϩ ϩ "Non-ROS") and thereby prevent alkylhydroperoxides from being formed in the first place. 2 As it can be calculated from the Michaelis-Menten equation, the CH 3 SeO 2 Ϫ turnover is more important than the actual methylselenol concentration. The formed methylseleninate can be assumed to exhibit a much lower pK a than methylselenol and should therefore be "expelled" from the membrane to the cytosol. It is tempting to speculate that this might explain the mutual saving effect of selenium and the lipid-protective vitamin E (42) .
The antioxidative point of view is further substantiated if we take into account that our data indicate that methylselenol and TrxR are capable of functionally replacing glutathione reductase (Eqs. 7-9). Since many important pathways in the cellular metabolism, such as the detoxification of alkylhydroperoxides and the GSH conjugation of xenobiotics, are dependent on a constant flow of reduced glutathione, it is tempting to speculate that TrxR via methylselenol is capable of partially maintaining these GSH fluxes under conditions in which glutathione reductase activity is impaired. Reduced thioredoxin has already been found to exhibit an efficient glutathione reductase-like activity (20) ; however, Trx is very bulky in comparison to methylselenol. Thus methylselenol may perform the GSSG reduction task in environments inaccessible to Trx. The effects of TrxR and methylselenol depicted here are not solely responsible for the chemopreventive effects of selenium. Nevertheless, they provide further insight into the chemical basis of the mechanisms mediating the positive effects of selenium.
